DEF 14A
SCHEDULE 14A INFORMATION
- Company
- Skye Bioscience, Inc.
- Filed
- June 10, 2015
- Period of Report
- June 10, 2015
- Accession Number
- 0001557240-15-000394
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →